human |
hsa_circ_CDYL |
hsa_circ_0008285 |
- |
breast cancer |
CDYL |
- |
Q
S
| |
More |
human |
hsa_circ_CDYL |
- |
- |
urinary bladder cancer |
CDYL |
- |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
- |
hepatocellular carcinoma |
CDYL |
hsa-miR-892a, hsa-miR-328-3p |
Q
M
| |
More |
human |
hsa_circ_CDYL |
- |
- |
mantle cell lymphoma |
CDYL |
- |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
- |
colon cancer |
CDYL |
hsa-miR-150-5p |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
- |
breast cancer |
CDYL |
hsa-miR-1275 |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
- |
multiple myeloma |
CDYL |
hsa-miR-1180 |
Q
| |
More |
human |
hsa_circ_CDYL |
hsa_circ_0008285 |
- |
colorectal cancer |
CDYL |
hsa-miR-382-5p |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
circCDYL |
Her2-receptor positive breast cancer |
CDYL |
hsa-miR-92b-3p |
Q
| |
More |
human |
hsa_circ_CDYL |
hsa_circ_0008285 |
CircCDYL |
nephroblastoma |
CDYL |
hsa-miR-145-5p |
Q
| |
More |
human |
hsa_circ_CDYL |
- |
circ_CDYL |
kidney disease |
CDYL |
hsa-miR-149-5p |
Q
| |
More |
human |
hsa_circ_CDYL |
hsa_circ_0008285 |
circ_0008285 |
polycystic ovary syndrome |
CDYL |
hsa-miR-4644 |
Q
| |
More |